Last update 07 Nov 2024

WO2023196866

Patent Mining

Overview

Basic Info

Drug Type
Antibody
Synonyms-
Target
CD200R
Mechanism-
Therapeutic Areas
NeoplasmsImmune System DiseasesInfectious Diseases+ [7]
Active Indication
Cardiovascular DiseasesDigestive System DisordersFemale Urogenital Diseases+ [9]
Inactive Indication-
Originator Organization
Gilead Sciences, Inc.Gilead Sciences, Inc.MiroBio Ltd.MiroBio Ltd.StartupOxford University Innovation Ltd.Oxford University Innovation Ltd.
Active Organization
Gilead Sciences, Inc.Gilead Sciences, Inc.Oxford University Innovation Ltd.Oxford University Innovation Ltd.
Inactive Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with WO2023196866
Login to view more data
100 Translational Medicine associated with WO2023196866
Login to view more data
100 Patents (Medical) associated with WO2023196866
Login to view more data
100 Deals associated with WO2023196866
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cardiovascular DiseasesDiscovery-
Oxford University Innovation Ltd.Oxford University Innovation Ltd.
12 Oct 2023
Cardiovascular DiseasesDiscovery-
Gilead Sciences, Inc.Gilead Sciences, Inc.
12 Oct 2023
Digestive System DisordersDiscovery-
Oxford University Innovation Ltd.Oxford University Innovation Ltd.
12 Oct 2023
Digestive System DisordersDiscovery-
Gilead Sciences, Inc.Gilead Sciences, Inc.
12 Oct 2023
Female Urogenital DiseasesDiscovery-
Gilead Sciences, Inc.Gilead Sciences, Inc.
12 Oct 2023
Female Urogenital DiseasesDiscovery-
Oxford University Innovation Ltd.Oxford University Innovation Ltd.
12 Oct 2023
HyperuricemiaDiscovery-
Oxford University Innovation Ltd.Oxford University Innovation Ltd.
12 Oct 2023
HyperuricemiaDiscovery-
Gilead Sciences, Inc.Gilead Sciences, Inc.
12 Oct 2023
Immune System DiseasesDiscovery-
Oxford University Innovation Ltd.Oxford University Innovation Ltd.
12 Oct 2023
Immune System DiseasesDiscovery-
Gilead Sciences, Inc.Gilead Sciences, Inc.
12 Oct 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free